Search Results - Christopher L. Cooper
- Showing 1 - 7 results of 7
-
1
T-cell-dependent mechanisms promote Ebola VLP-induced antibody responses, but are dispensable for vaccine-mediated protection<subtitle>Protection from EBOV in the absence of antibo... by Christopher L Cooper, Karen A Martins, Sabrina M Stronsky, David P Langan, Jesse Steffens, Sean Van Tongeren, Sina Bavari
Published in Emerging Microbes and Infections (2017-01-01)Get full text
Article -
2
Mapping the antibody response to Lassa virus vaccination of non-human primatesResearch in context by Adrian S. Enriquez, Ruben Diaz Avalos, Diptiben Parekh, Christopher L. Cooper, Gavin Morrow, Thomas W. Geisbert, Christopher L. Parks, Kathryn M. Hastie, Erica Ollmann Saphire
Published in EBioMedicine (2025-04-01)Get full text
Article -
3
Prevalence of human filovirus infections in sub-Saharan Africa: A systematic review and meta-analysis protocol by Christopher S. Semancik, Christopher L. Cooper, Thomas S. Postler, Matt Price, Heejin Yun, Marija Zaric, Monica Kuteesa, Nina Malkevich, Andrew Kilianski, Swati B. Gupta, Suzanna C. Francis
Published in Systematic Reviews (2024-08-01)Get full text
Article -
4
Seroprevalence of Antibodies to Filoviruses with Outbreak Potential in Sub-Saharan Africa: A Systematic Review to Inform Vaccine Development and Deployment by Christopher S. Semancik, Hilary S. Whitworth, Matt A. Price, Heejin Yun, Thomas S. Postler, Marija Zaric, Andrew Kilianski, Christopher L. Cooper, Monica Kuteesa, Sandhya Talasila, Nina Malkevich, Swati B. Gupta, Suzanna C. Francis
Published in Vaccines (2024-12-01)Get full text
Article -
5
An Intranasal Challenge Model in African Green Monkeys (<i>Chlorocebus aethiops</i>) for Mild-to-Moderate COVID-19 Disease Caused by Subvariant XBB.1.5 by Nadia Storm, Ming Lo, Nicholas Crossland, Margaux Seyler-Schmidt, Hilary Staples, Daniela Silva-Ayala, Ambre M. Laprise, Lauren St. Denis, Kyle Grosz, Aoife O’Connell, Hans Gertje, Tillie Ripin, Claire Decker, M. Mazur, Colleen Thurman, Marlene Espinoza, Gavin Morrow, Christopher L. Parks, Christopher L. Cooper, Anthony Griffiths
Published in Viruses (2025-10-01)Get full text
Article -
6
Nonhuman Primates Are Protected against Marburg Virus Disease by Vaccination with a Vesicular Stomatitis Virus Vector-Based Vaccine Prepared under Conditions to Allow Advancement t... by Christopher L. Cooper, Gavin Morrow, Maoli Yuan, John W. Coleman, Fuxiang Hou, Lucia Reiserova, Shui L. Li, Denise Wagner, Alexei Carpov, Olivia Wallace-Selman, Kristie Valentin, Yesle Choi, Aaron Wilson, Andrew Kilianski, Eddy Sayeed, Krystle N. Agans, Viktoriya Borisevich, Robert W. Cross, Thomas W. Geisbert, Mark B. Feinberg, Swati B. Gupta, Christopher L. Parks
Published in Vaccines (2022-09-01)Get full text
Article -
7
Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trialsResearch in context by Christopher L. Cooper, Gavin Morrow, Maoli Yuan, Thomas S. Postler, Maxwell L. Neal, Robert W. Cross, Courtney Woolsey, Krystle N. Agans, Viktoriya Borisevich, Ryan P. McNamara, Caroline Atyeo, Vicky Roy, Daritza Germosen, Fuxiang Hou, Shui L. Li, Lucia Reiserova, Yesle Choi, Aaron Wilson, Denise Wagner, Olivia Wallace-Selman, Alexei Carpov, Fuqiang Geng, Deborah J. Frederick, Joanne DeStefano, Anne M. Ercolini, Adrian S. Enriquez, Kathryn M. Hastie, Suzane Ramos da Silva, Eddy Sayeed, John W. Coleman, Andrew Kilianski, Galit Alter, Erica Ollmann Saphire, John D. Aitchison, Thomas W. Geisbert, Swati B. Gupta, Mark B. Feinberg, Christopher L. Parks
Published in EBioMedicine (2025-04-01)Get full text
Article
